Additionally, CCN2 expression was higher in colorectal adenocarcinoma (COAD) tissues than in normal tissues across various clinicopathological features, including sex, nodal metastasis, and TP53 mutation status (Figure 2C). This evidence concerns the gene CCN2 and colon adenocarcinoma.